EUVIMEDEUVIMED entdecken
Crossref

Prevalence of New Delhi Metallo-β-lactamase gene and antibiotic susceptibility of clinical Klebsiella pneumoniae isolates from selected hospitals in Calabar, Nigeria

I. I. Ukam, N. O. Umoh, S. O. Iyam, B. M. W. Nwibari, J. C. Ugwu, S. A. Ben, O. M. Ogba

African Journal of Clinical and Experimental Microbiology · 2026 · 27 (2) · 188-194

DOI: 10.4314/ajcem.v27i2.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Journal of Clinical and Experimental Microbiology, 2026. Verfasst von I. I. Ukam und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The global spread of extended spectrum beta-lactamases (ESBL) and carbapenemase-producing strains of Klebsiella pneumoniae, is considered a major public health threat to humans. Antimicrobial resistance mediated by New Delhi Metallo-β-lactamase (NDM) enzyme has become a major threat to treatment outcome. This study is aimed at investigating the carriage rate of blaNDM gene among multidrug resistant (MDR) clinical K. pneumoniae isolates from four selected health facilities in Calabar, Nigeria.Methodology: This was a laboratory-based study of 70 confirmed K. pneumoniae isolates recovered from various clinical sources at the University of Calabar Teaching Hospital (UCTH), General Hospital Calabar (GHC), Faith Foundation Specialist Clinic (FFSC) and Bakor Medical Centre Calabar (BMCC) using the Vitek® 2 Compact system, with antibiotic susceptibility testing performed by the Kirby-Bauer disc diffusion method. Molecular detection of blaNDM gene in 15 selected MDR isolates was carried out by conventional PCR assay and agarose gel electrophoresis detection of the gene amplicon.

Results

The distribution of the confirmed isolates according to healthcare facilities showed that the highest frequency of K. pneumoniae isolates was obtained from UCTH (52.9%, n=37), followed by GHC (17.1%, n=12), BMCC (15.7%, n=11) and FFSC (14.3%, n=10). Urine sample accounted for the highest frequency of the isolates (40.0%, n=28), followed by sputum (31.4%, n=22), wound swabs (8.6%, n=6), and blood (5.7%, n=4) while the frequency of isolates was higher among inpatients (57.1%, n=40) than outpatients (42.9%, n=30). The susceptibility of the isolates to meropenem, ertapenem, piperacillin/ tazobactam, amoxicillin/clavulanate, ciprofloxacin, gentamicin and ceftazidime was 57.1% (n=40), 54.3% (n=38), 51.4% (n=36), 50.0% (n=35), 48.6% (n=34), 47.1% (n=33) and 17.1% (n=12) respectively. Eighteen (25.7%) isolates were MDR K. pneumoniae strains while blaNDM gene was detected in 9 (60.0%) of 15 MDR isolates tested.

Conclusion

The high prevalence of the resistance gene in this study setting underscores the urgent need for an informed and discrete use of antimicrobial drugs, particularly β-lactam antibiotics, for management of bacterial infections to prevent further spread of drug-resistant K. pneumoniae strains.

Zitieren

APA

Ukam, I. I., Umoh, N. O., Iyam, S. O., Nwibari, B. M. W., Ugwu, J. C., Ben, S. A., & Ogba, O. M. (2026). Prevalence of New Delhi Metallo-β-lactamase gene and antibiotic susceptibility of clinical Klebsiella pneumoniae isolates from selected hospitals in Calabar, Nigeria. African Journal of Clinical and Experimental Microbiology, 27(2), 188-194. https://doi.org/10.4314/ajcem.v27i2.8

Vancouver

Ukam II, Umoh NO, Iyam SO, Nwibari BMW, Ugwu JC, Ben SA, et al. Prevalence of New Delhi Metallo-β-lactamase gene and antibiotic susceptibility of clinical Klebsiella pneumoniae isolates from selected hospitals in Calabar, Nigeria. African Journal of Clinical and Experimental Microbiology. 2026;27(2):188-194. doi:10.4314/ajcem.v27i2.8

BibTeX
@article{Ukam2026,
  author = {Ukam, I. I. and Umoh, N. O. and Iyam, S. O. and Nwibari, B. M. W. and Ugwu, J. C. and Ben, S. A. and Ogba, O. M.},
  title = {Prevalence of New Delhi Metallo-β-lactamase gene and antibiotic susceptibility of clinical Klebsiella pneumoniae isolates from selected hospitals in Calabar, Nigeria},
  journal = {African Journal of Clinical and Experimental Microbiology},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {188--194},
  doi = {10.4314/ajcem.v27i2.8}
}
Kostenlos starten →